These results indicate that CDDO-Me inhibits STAT3 phosphorylation in human melanoma-conditioned macrophages and suggest CDDO-Me-mediated changes in myeloid activation may be due, at least in part, to suppression of STAT3 activation. The gene discussed is STAT3; the disease is melanoma.